BioSante Pharmaceuticals Inc. (BPAX) Stock Quote

Detailed Quote for BioSante Pharmaceuticals Inc. (BPAX)

After Hours: $ 1.11

0.06 (+5.71%)

Volume: 429.26 k

7:59 PM EST Feb 6, 2012

close 52 Week Information

52 Week High

July 13, 2011

Close: 4.02

52 Week Low

December 19, 2011

Close: 0.38

Today

Last Price
1.05

Change $
0.31

Change %
41.89%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
0.76

High
1.06

Low
0.6347

Prev Close
0.74

Last Trade
4:00

Volume
28.8 m

52 Wk Hi
4.02

52 Wk Low
0.38

Market Cap
115.51 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
110,009,815

EPS (TTM)
-0.67

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for BioSante Pharmaceuticals Inc. (BPAX)

Sector News | Topic News

News for BPAX

Mon, Feb 06, 2012

9:05 AM

Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc. - Business Wire

Tue, Jan 31, 2012

8:20 AM

Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies - Marketwire

7:55 AM

BioSante Pharmaceuticals Provides Corporate Update - Business Wire

Tue, Jan 17, 2012

8:20 AM

Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Rally - Marketwire

Wed, Jan 11, 2012

6:20 PM

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by BioSante Pharmaceuticals, Inc. - Business Wire

6:30 AM

Robbins Umeda LLP Announces an Investigation of BioSante Pharmaceuticals, Inc. - Business Wire

Thu, Jan 05, 2012

8:16 AM

Battered Down Shares of Cell Therapeutics and BioSante Look to Rebound in 2012 - Marketwire

Wed, Dec 14, 2011

4:06 PM

BioSante Pharmaceuticals Announces Results from LibiGel® Efficacy Trials - Business Wire

Thu, Dec 01, 2011

8:16 AM

Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day - Marketwire

7:00 AM

Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease - PR Newswire

Tue, Nov 29, 2011

9:00 AM

BioSante Pharmaceuticals Announces Issuance of New LibiGel® Method of Use Patent - Business Wire

Mon, Nov 21, 2011

7:55 AM

BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index - Business Wire

Thu, Nov 17, 2011

8:16 AM

Cheap Valuations for Dendreon and BioSante Spark Investor Interest - Marketwire

Wed, Nov 16, 2011

7:55 AM

BioSante Pharmaceuticals Announces Positive LibiGel® Pharmacokinetic Study Results - Business Wire

Wed, Nov 09, 2011

4:30 PM

BioSante Pharmaceuticals Reports Financial Results for Third Quarter 2011 and Pipeline Update - Business Wire

Fri, Nov 04, 2011

8:16 AM

Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected - Marketwire

Thu, Oct 20, 2011

8:16 AM

Late Stage Drugs From BioSante and AEterna Zentaris Could Reawaken Interest in Biotech Sector - Marketwire

Mon, Oct 10, 2011

8:25 AM

BioSante Pharmaceuticals and Sangamo Biosciences -- Aiming for Efficiency - Marketwire

Mon, Sep 19, 2011

8:27 AM

Long Term Growth Prospects From BioSante and Avanir Pharmaceuticals Remain Bright - Marketwire

Tue, Sep 06, 2011

8:16 AM

Late-Stage Products From BioSante and Keryx Gaining Momentum - Marketwire

More News for BPAX >>

Tags for BioSante Pharmaceuticals Inc.

Research stocks or mutual funds related to BioSante Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to BPAX. The keywords below have been associated to BPAX by either user submission or electronic means.

herbal menopause dhea hormone symptoms of menopause testosterone menopause increase libido female menopause know menopause women's libido pharmaceuticals companies thyroid hormone replacement decreased libido women women libido dupont pharmaceuticals decreased libido Biological Products estrogen replacement therapy womens libido woman libido human growth hormone pharma license libido sexuality female progesterone cream drug delivery women menopause pharmaceutical sales hormones aphrodisiacs for women testosterone patch menopause hormone replacement therapy no libido pharma Testosterone replacement therapy pharmaceutical development loss of libido pharmaceutical reports pharmaceutical magazine hormones female Drugs women testosterone natural hrt testosterone women low female enhancement bioidentical hormone replacement therapy menopause treatment female libido drug testosterone female low elan pharmaceutical pharmaceutical sale menopause relief